Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Terbinafine, Fluconazole, and Itraconazole in Onychomycosis
NCT03171584Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jul 2017
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial in onychomycosis comparing Terbinafine group, Fluconazole group and Itraconazole group (3 arms). Primary endpoint: Cure rate of patients at 1 year. Status: unknown.
02
Drugs
Terbinafinefluconazoleitraconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT03171584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171584.